Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL)

Profile

Company profile for Madrigal Pharmaceuticals, Inc. (MDGL)
MetricValue
Full NameMadrigal Pharmaceuticals, Inc.
TickerNASDAQ: MDGL
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitemadrigalpharma.com
Employees528

Key Metrics

Madrigal Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$505.23
Price, 1D Change+2.29%
Market Cap$11B
-
PE Ratio-
Beta0.84
Revenue$180M
Revenue, 1Y Change+100.00%
EPS-$21.90
EPS, 1Y Change-9.54%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Madrigal Pharmaceuticals, Inc. chart

Events

Madrigal Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:35
Next SplitN/AN/A
Last Ticker ChangeSNTA
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

MDGL Estimates
MetricDateValue
EPS-$21.90
EPS Estimate-$10.10
EPS Est. Change+53.89%
Revenue$180.13M
Revenue Estimate$948.78M
Revenue Est. Change+426.71%
Current Price$505.23
Price Target-$591.00
Price Tgt. Change-+16.98%

🔒 Log In To Unlock Full Data

EPS

MDGL EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$19.48-$19.99-2.64%
-$23.47-$21.90+6.69%
-$10.10N/A+53.89%
$2.46N/A+111.22%
MDGL EPS reported versus estimate values chart

Revenue

MDGL revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
-$0.00-
$174.49M$180.13M+3.23%
$948.78MN/A+426.71%
$1.45BN/A+704.32%
MDGL revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

MDGL Performance
MetricDateValue
Price, 1Y+84.31%
Price, 3Y+68.42%
Market Cap, 1Y+90.23%
Market Cap, 3Y+111.30%
Revenue, 1Y+100.00%
Revenue, 3Y+100.00%
EPS, 1Y-9.54%
EPS, 3Y-49.74%

🔒 Log In To Unlock Full Data

Technical Indicators

MDGL Technical Indicators
MetricDateValue
Current Price$505.23
SMA 200$401.25
SMA 200 vs Price-20.58%
SMA 50$552.23
SMA 50 vs Price+9.30%
Beta0.84
ATR$23.49
14-Day RSI34.52
10-Day Volatility49.36%
1-Year Volatility50.17%

Dividends

MDGL Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

MDGL Income & Profitability
MetricDateValue
Revenue$180.13M
EPS-$21.90
Gross Profit$172.80M
Gross Margin95.93%
Operating Profit-$497.88M
Operating Margin-276.39%
Net Income-$465.89M
Net Margin-258.64%
EBITDA-$450.13M

🔒 Log In To Unlock Full Data

Financial Health

MDGL Financial Health
MetricDateValue
Debt To Equity0.16
Current Ratio6.10
Quick Ratio5.90
-
F-Score2
Altman Z-Score21.23

Valuations

MDGL Valuations
MetricDateValue
PE Ratio-
PS Ratio15.49
PB Ratio18.34
EV/EBITDA-34.99
Enterprise ValueN/A-

Balance Sheet

MDGL Balance Sheet
MetricDateValue
Book Value$754.38M
Cash & Equivalents$931.25M
Total Assets$1.04B
Current Assets$1.03B
Total Liabilities$287.86M
Current Liabilities$169.28M
Total Debt$119.57M
Short Term Debt$983.00K
Accounts Payable$43.60M

Expenses

MDGL Expenses
MetricDateValue
Total Expenses$678.01M
Operating Expenses$671.78M
Cost Of Goods Sold$7.33M
SG&A$0.00
D&A$1.10M
Interest Expense$0.00
Income Tax$0.00

Cash Flow

MDGL Cash Flow
MetricDateValue
CFO-$455.57M
CFI-$274.39M
CFF$735.06M
Capex$6.46M
Free Cash Flow-$462.03M

Recent analyst updates

MDGL Recent analyst updates
MetricDateValue
Piper Sandler→
B. Riley Securities→
HC Wainwright & Co.→
Oppenheimer→
Truist Securities→
Canaccord Genuity→
HC Wainwright & Co.→
Citizens→
Cantor Fitzgerald→
B of A Securities→

Analyst sentiment

Sentiment over the past month
MDGL analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
MDGL institutional ownership distribution chart

Screeners with MDGL

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl

FAQ

  • What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?

    The ticker symbol for Madrigal Pharmaceuticals, Inc. is NASDAQ:MDGL

  • Does Madrigal Pharmaceuticals, Inc. pay dividends?

    No, Madrigal Pharmaceuticals, Inc. does not pay dividends

  • What sector is Madrigal Pharmaceuticals, Inc. in?

    Madrigal Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Madrigal Pharmaceuticals, Inc. in?

    Madrigal Pharmaceuticals, Inc. is in the Biotechnology industry

  • What country is Madrigal Pharmaceuticals, Inc. based in?

    Madrigal Pharmaceuticals, Inc. is headquartered in United States

  • When did Madrigal Pharmaceuticals, Inc. go public?

    Madrigal Pharmaceuticals, Inc. initial public offering (IPO) was on February 6, 2007

  • Is Madrigal Pharmaceuticals, Inc. in the S&P 500?

    No, Madrigal Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is Madrigal Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Madrigal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

  • Is Madrigal Pharmaceuticals, Inc. in the Dow Jones?

    No, Madrigal Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Madrigal Pharmaceuticals, Inc. last earnings report?

    Madrigal Pharmaceuticals, Inc.'s most recent earnings report was on November 4, 2025

  • When does Madrigal Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Madrigal Pharmaceuticals, Inc. is February 26, 2026